A systems approach to solving cancer

NEUVOGEN is an immunoncology company applying a systems approach to develop therapeutic whole cell cancer vaccines to transform how cancer is treated.

The NEUVOGEN platform represents the next generation in therapeutic whole cell cancer vaccines.

NEUVOGEN’s research programs focus on therapeutic cancer vaccines to treat a wide range of tumor types across numerous solid tumor indications.